WAVE Life Sciences (NASDAQ: WVE) reported Q1 EPS of ($0.27), $0.22 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $12.9 million versus the consensus estimate of $38.6 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.